Assignee
AXIKIN PHARMACEUTICALS INC
US·15 granted patents·3 pending applications·64 citations·filing 2002–2016
Top patents by PatentIndex Score
18 records- 0185US8916555B23,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2013·Granted Dec 23, 2014·8 cites·50 claims
- 0283US7674797B22-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disordersAXIKIN PHARMACEUTICALS INC·Filed 2004·Granted Mar 9, 2010·20 cites·10 claims
- 0381US7700586B2Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disordersAXIKIN PHARMACEUTICALS INC·Filed 2002·Granted Apr 20, 2010·19 cites·19 claims
- 0475US9156799B2Isotopically enriched arylsulfonamide CCR3 antagonistsAXIKIN PHARMACEUTICALS INC·Filed 2013·Granted Oct 13, 2015·2 cites·7 claims
- 0575US7829685B2Regulation of kinase, regulated in COPD kinase (RC kinase)AXIKIN PHARMACEUTICALS INC·Filed 2004·Granted Nov 9, 2010·10 cites·12 claims
- 0674US9206186B22-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disordersAXIKIN PHARMACEUTICALS INC·Filed 2013·Granted Dec 8, 2015·2 cites·7 claims
- 0772US9187425B22,5-disubstituted arylsulfonamide CCR3 antagonistsAXIKIN PHARMACEUTICALS INC·Filed 2013·Granted Nov 17, 2015·1 cites·24 claims
- 0872US8563544B22,5-disubstituted arylsulfonamide CCR3 antagonistsAXIKIN PHARMACEUTICALS INC·Filed 2012·Granted Oct 22, 2013·1 cites·20 claims
- 0970US9365556B23,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2013·Granted Jun 14, 2016·1 cites·45 claims
- 1060US9382237B23,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2014·Granted Jul 5, 2016·0 cites·53 claims
- 1160US9346792B23,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2014·Granted May 24, 2016·0 cites·54 claims
- 1253US9540351B2Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2014·Granted Jan 10, 2017·0 cites·44 claims
- 1351US2016031841A12,5-disubstituted arylsulfonamide ccr3 antagonistsAXIKIN PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1449US9730914B23,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2016·Granted Aug 15, 2017·0 cites·37 claims
- 1549US9546163B23,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2015·Granted Jan 17, 2017·0 cites·41 claims
- 1649US2014221428A1Arylsulfonamide ccr3 antagonistsAXIKIN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1744US2017079954A1Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitorsAXIKIN PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1843US9637460B2Isotopically enriched arylsulfonamide CCR3 antagonistsAXIKIN PHARMACEUTICALS INC·Filed 2015·Granted May 2, 2017·0 cites·47 claims
Join the waitlist — get patent alerts
Get an alert when AXIKIN PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →